ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma
Article in Pathology - Research and Practice (March 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Pathology - Research and Practice (March 2024)
Article in Journal of Proteomics (November 2023)
Article in Scientific Reports (April 2023)